STOP 2030: TOWARDS THE INTERRUPTION OF TRANSMISSION OF SOIL-TRANSMITTED HELMINTHS: PROMOTING IMPLEMENTATION OF RESEARCH RESULTS OF A FIXED-DOSE COMBINATION OF CO-FORMULATED IVERMECTIN AND ALBENDAZOLE

Información del proyecto

STOP2030

Identificador del acuerdo de subvención: 101103089

DOI

10.3030/101103089

Fecha de la firma de la CE 7 Marzo 2023

Fecha de inicio 1 Julio 2023

Fecha de finalización 30 Junio 2027

Financiado con arreglo a

• Health

Coste total

€ 5 046 435,75

Aportación de la UE

€ 3 553 502,25

Coordinado por

LABORATORIOS LICONSA SA
Spain

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (9)

Communication Plan

Internal Communication plan to define the internal communication channels and tools to promote the exchange of ideas and the sharing of information among the Consortium's members.

Clinical data management plan (cDMP)

Description of the data management life cycle for the data to be collected, processed and/or generated by STOP2030 project

Registration number of clinical study

Trial registration in public access trial repositories

Clinical monitoring plan

Plan establishing the guidelines for conducting monitoring visits and timelines

Terms of reference for project committees

Define the different project Committees, scope, frequency and participant

Genomic protocol

Protocol for reporting on genomic data generation and submission to open access repositories, standardisation of code description and availability

Risk management record (Y1)

List of potential risk and mitigation plans to either avoid or minimize

Data analysis and interpretation

Analyse and interpretate data in collaboration with Consortium members

Formative study on Acceptability & Feasibility completed

Protocol for the formative study on acceptability and feasibility to be implemented in Ghana and Kenya

Websites, patent fillings, videos etc. (1)

Launched Project - WEBSITE

Project Website and as per good practices, all work packages leads will be listed.

Publicaciones

Peer reviewed articles (3)

Implications of global health funding patterns for implementation of a novel soil-transmitted helminth and lymphatic filariasis medicine: Ivermectin/albendazole fixed-dose combination

Autores: Israel Wuresah, Alan Brooks, Nikita Kubal, Marina Gold, Alejandro Krolewiecki, Julie Jacobson
Publicado en: PLOS Neglected Tropical Diseases, Edición 20, 2026, ISSN 1935-2735
Editor: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PNTD.0014458

Fixed-dose ivermectin for Mass Drug Administration: Is it time to leave the dose pole behind? Insights from an Individual Participant Data Meta-Analysis

Autores: Adriana Echazu, Daniela Bonanno, Pedro Emanuel Fleitas, Julie Jacobson, Gabriela Matamoros, Charles Mwandawiro, Wendemagegn Enbiale, Áuria de Jesus, Alan Brooks, Alejandro Javier Krolewiecki
Publicado en: PLOS Neglected Tropical Diseases, Edición 19, 2025, ISSN 1935-2735
Editor: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PNTD.0013059

Cost-effectiveness of soil-transmitted helminthiasis intervention programmes: A scoping review

Autores: Michael Odhiambo, Israel Wuresah, Geofrey Chepchieng, Nikita Kubal, Alejandro Krolewiecki, Charles Mwandawiro, Alan Brooks, Collins Okoyo
Publicado en: PLOS Neglected Tropical Diseases, Edición 20, 2026, ISSN 1935-2735
Editor: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PNTD.0014317